« Previous
Next »
Titles
- IRB waiver or alteration of informed consent for clinical investigations involving no more than minimal risk to human subjects: guidance for sponsors, investigators, and institutional review boards1
- Idaho Medicaid Fraud Control Unit: 2018 onsite inspection1
- Illegal marijuana: opportunities exist to improve oversight of state and local eradication efforts : report to Congressional requesters1
- Illicit opioids: while greater attention given to combating synthetic opioids, agencies need to better assess their efforts : report to Congressional requesters1
- Illinois Medicaid Fraud Control Unit: 2019 onsite review1
- Immigration detention: ICE efforts to address COVID-19 in detention facilities : report to Congressional committees1
- Immigration detention: ICE needs to strengthen oversight of informed consent for medical care : report to congressional requesters1
- Immigration detention: care of pregnant women in DHS facilities : report to Congressional requesters1
- Impact of Medicare disproportionate share hospital payment cap on rural and urban hospitals1
- Impact of the COVID-19 pandemic on the hospital and outpatient clinician workforce: challenges and policy responses1
- Implanted brain-computer interface (BCI) devices for patients with paralysis or amputation: non-clinical testing and clinical considerations : guidance for industry and Food and Drug Administration staff1
- Implementation of acceptable full-length and abbreviated donor history questionnaires and accompanying materials for use in screening donors of blood and blood components: guidance for industry1
- Implementing and sustaining zero suicide: health care system efforts to prevent suicide1
- Importation of certain FDA approved human prescription drugs, including biological products, and combination products under section 801(d)(1)(b) of the Federal Food, Drug, and Cosmetic Act1
- Importation of prescription drugs final rule: questions and answers1
- Imported seafood safety: FDA and USDA could strengthen efforts to prevent unsafe drug residues : report to the chairman, Committee on Appropriations, U.S. Senate1
- Improper payments: improvements needed in CMS and IRS controls over health insurance premium tax credit : report to Congressional committees1
- Improving access to and enrollment in Programs of All-Inclusive Care for the Elderly (PACE)1
- Improving and strengthening employer-sponsored insurance1
- Improving data infrastructure for patient-centered outcomes research for people with intellectual and developmental disabilities1